Analome
Accelerating Biotech with Custom Genomics, Bioinformatics, and Strategic Consulting

Advanced genomics and bioinformatics have fundamentally changed the way biotech science is performed. Sequencing projects that previously required years and tens of millions of dollars can now be completed in days for thousands of dollars.

These developments have significantly lowered the barrier to entry for companies that develop biotech products. New species can now be quickly sequenced and analyzed for a multitude of attributes, enabling companies to select promising candidates at a much faster pace.

Gathering important genomic information early in product development also greatly reduces investment risk — for example: potential products that may be genetically predisposed to disease or allergenicity can be eliminated early, freeing up valuable time and research dollars to be spent on the most promising candidates.

Unfortunately, companies drawn by the promise of advanced genomics and bioinformatics are often met with new challenges and risks. Inexperienced teams may not have the necessary skills to design and manage genomics projects. Or they may lack the expertise to organize and evaluate data obtained from a sequencing project after it is completed. This is where a company like Analome can help.

Analome harnesses the power of leading-edge genomics and bioinformatics to help clients accelerate product development. The team at Analome draws on decades of industry experience to help clients quickly design genomics projects and extract valuable insights with bioinformatics.

The company also maintains an expert network of professionals and organizations in associated fields to further customize solutions depending on the unique needs of the client.

“We make it easy for clients to target their R&D investment to the most promising new product candidates regardless of company size or project scope,” says David Kovalic, president of Analome.

Analome begins each project by evaluating the needs and capabilities of the client. The results of this evaluation are used to craft a custom solution that provides the client with the appropriate skill sets and insights needed to complete the project. The expert team at Analome will also consult with clients across their entire pipeline, helping them to adopt and maintain best practices long after the initial engagement ends.

In a recent example of client success, Analome worked with a mid-size agricultural biotech company to assess their entire R&D pipeline using next-generation sequencing and advanced bioinformatics algorithms. This significant undertaking allowed the company to focus their downstream efforts exclusively on high quality candidates, eliminating unnecessary expenses and targeting their resources to products with the greatest potential of winning. These research results saved the client from spending millions of dollars on low quality product candidates, and the company went on to achieve a successful initial public offering (IPO).

Analome has also helped a variety of clients quickly secure critical regulatory approvals at the precommercial stage using state-of-the art methods — in full alignment with current global regulatory standards.

In every case, Analome helps clients achieve their goal of accelerating development pipelines and bringing successful products to market faster than they ever could have before. As analytical methods in the fields of genomics and bioinformatics continue to evolve, the team at Analome sees a bright future in leveraging ever-increasing speed, capability, and cost savings for clients.